Hematopoietic stem cell transplantation (HSCT) is the transplantation of multipotent hematopoietic stem cells, usually derived from bone marrow, peripheral blood, or umbilical cord blood. It is a medical procedure in the fields of hematology and oncology, most often performed for patients with certain cancers of the blood or bone marrow, such as multiple myeloma or leukemia. In these cases, the recipient's immune system is usually destroyed with radiation or chemotherapy before the transplantation. Infection and graft-versus-host disease is a major complication of allogenic HSCT.
Hematopoietic stem cell transplantation remains a dangerous procedure with many possible complications; it is reserved for patients with life-threatening diseases. As the survival of the procedure increases, its use has expanded beyond cancer, such as autoimmune diseases.[1][2]
Many recipients of HSCTs are multiple myeloma[3] or leukemia patients[4] who would not benefit from prolonged treatment with, or are already resistant to, chemotherapy. Candidates for HSCTs include pediatric cases where the patient has an inborn defect such as severe combined immunodeficiency or congenital neutropenia with defective stem cells, and also children or adults with aplastic anemia[5] who have lost their stem cells after birth. Other conditions[6] treated with stem cell transplants include sickle-cell disease, myelodysplastic syndrome, neuroblastoma, lymphoma, Ewing's sarcoma, desmoplastic small round cell tumor, chronic granulomatous disease and Hodgkin's disease. More recently non-myeloablative, or so-called "mini transplant," procedures have been developed that require smaller doses of preparative chemo and radiation. This has allowed HSCT to be conducted in the elderly and other patients who would otherwise be considered too weak to withstand a conventional treatment regimen.
A total of 50,417 first hematopoietic stem cell transplants were reported as taking place worldwide in 2006, according to a global survey of 1327 centers in 71 countries conducted by the Worldwide Network for Blood and Marrow Transplantation. Of these, 28,901 (57%) were autologous and 21,516 (43%) were allogenetic (11,928 from family donors and 9,588 from unrelated donors). The main indications for transplant were lymphoproliferative disorders (54.5%) and leukemias (33.8%), and the majority took place in either Europe (48%) or the Americas (36%).[7] In 2009, according to the world marrow donor association, stem cell products provided for unrelated transplantation worldwide had increased to 15,399 (3,445 bone marrow donations, 8,162 peripheral blood stem cell donations, and 3,792 cord blood units).[8]
Autologous HSCT requires the extraction (apheresis) of haematopoietic stem cells (HSC) from the patient and storage of the harvested cells in a freezer. The patient is then treated with high-dose chemotherapy with or without radiotherapy with the intention of eradicating the patient's malignant cell population at the cost of partial or complete bone marrow ablation (destruction of patient's bone marrow function to grow new blood cells). The patient's own stored stem cells are then transfused into his/her bloodstream, where they replace destroyed tissue and resume the patient's normal blood cell production. Autologous transplants have the advantage of lower risk of infection during the immune-compromised portion of the treatment since the recovery of immune function is rapid. Also, the incidence of patients experiencing rejection (graft-versus-host disease) is very rare due to the donor and recipient being the same individual. These advantages have established autologous HSCT as one of the standard second-line treatments for such diseases as lymphoma.[9] However, for others such as Acute Myeloid Leukemia, the reduced mortality of the autogenous relative to allogeneic HSCT may be outweighed by an increased likelihood of cancer relapse and related mortality, and therefore the allogeneic treatment may be preferred for those conditions.[10] Researchers have conducted small studies using non-myeloablative hematopoietic stem cell transplantation as a possible treatment for type I (insulin dependent) diabetes in children and adults. Results have been promising; however, as of 2009[update] it was premature to speculate whether these experiments will lead to effective treatments for diabetes.[11]
Allogeneic HSCT involves two people: the (healthy) donor and the (patient) recipient. Allogeneic HSC donors must have a tissue (HLA) type that matches the recipient. Matching is performed on the basis of variability at three or more loci of the HLA gene, and a perfect match at these loci is preferred. Even if there is a good match at these critical alleles, the recipient will require immunosuppressive medications to mitigate graft-versus-host disease. Allogeneic transplant donors may be related (usually a closely HLA matched sibling), syngeneic (a monozygotic or 'identical' twin of the patient - necessarily extremely rare since few patients have an identical twin, but offering a source of perfectly HLA matched stem cells) or unrelated (donor who is not related and found to have very close degree of HLA matching). Unrelated donors may be found through a registry of bone marrow donors such as the National Marrow Donor Program. People who would like to be tested for a specific family member or friend without joining any of the bone marrow registry data banks may contact a private HLA testing laboratory and be tested with a mouth swab to see if they are a potential match.[12] A "savior sibling" may be intentionally selected by preimplantation genetic diagnosis in order to match a child both regarding HLA type and being free of any obvious inheritable disorder. Allogeneic transplants are also performed using umbilical cord blood as the source of stem cells. In general, by transfusing healthy stem cells to the recipient's bloodstream to reform a healthy immune system, allogeneic HSCTs appear to improve chances for cure or long-term remission once the immediate transplant-related complications are resolved.[13][14][15]
A compatible donor is found by doing additional HLA-testing from the blood of potential donors. The HLA genes fall in two categories (Type I and Type II). In general, mismatches of the Type-I genes (i.e. HLA-A, HLA-B, or HLA-C) increase the risk of graft rejection. A mismatch of an HLA Type II gene (i.e. HLA-DR, or HLA-DQB1) increases the risk of graft-versus-host disease. In addition a genetic mismatch as small as a single DNA base pair is significant so perfect matches require knowledge of the exact DNA sequence of these genes for both donor and recipient. Leading transplant centers currently perform testing for all five of these HLA genes before declaring that a donor and recipient are HLA-identical.
Race and ethnicity are known to play a major role in donor recruitment drives, as members of the same ethnic group are more likely to have matching genes, including the genes for HLA.[1]
To limit the risks of transplanted stem cell rejection or of severe graft-versus-host disease in allogeneic HSCT, the donor should preferably have the same human leukocyte antigens (HLA) as the recipient. About 25 to 30 percent of allogeneic HSCT recipients have an HLA-identical sibling. Even so-called "perfect matches" may have mismatched minor alleles that contribute to graft-versus-host disease.
In the case of a bone marrow transplant, the HSC are removed from a large bone of the donor, typically the pelvis, through a large needle that reaches the center of the bone. The technique is referred t
o as a bone marrow harvest and is performed under general anesthesia.
Go here to see the original:
Hematopoietic stem cell transplantation - Wikipedia, the free ...
- Bone Marrow Transplant Stem Cell Transplant patient shares her experience at International Oncology - Video - March 29th, 2013 [March 29th, 2013]
- Ellen's journey through lymphoma and a stem cell transplant. - Video - April 23rd, 2013 [April 23rd, 2013]
- Stem Cell Transplant Hangout - Video - May 3rd, 2013 [May 3rd, 2013]
- Interview with Sarah Kelm of the Immunotherapy - May 13th, 2013 [May 13th, 2013]
- 'Off-the-shelf' virus-specific T-cells fight viral infections in stem cell transplant patients - May 15th, 2013 [May 15th, 2013]
- Dr. Patrick Stiff Named Chair of SWOG Bone Marrow and Stem Cell Transplantation Committee - May 18th, 2013 [May 18th, 2013]
- 2013 Blume-Schmidt Memorial Lecture - Stem cell transplant experts gather to honor pioneer - Video - May 27th, 2013 [May 27th, 2013]
- Study Shows Significantly Improved Survival Rates for Stem Cell Transplant Recipients - May 29th, 2013 [May 29th, 2013]
- Roy Jones - June 8th, 2013 [June 8th, 2013]
- Study sets guidelines for stem cell transplants in older patients with myelodysplastic syndromes - June 25th, 2013 [June 25th, 2013]
- Karmanos Cancer Center Blood and Marrow Stem Cell Transplant Program Gets Foundadtion Accreditation - June 25th, 2013 [June 25th, 2013]
- Bone marrow stem cell transplant reduces insulin usage in type 2 diabetes patients - June 29th, 2013 [June 29th, 2013]
- View From My Stem Cell Transplant Ward - Video - June 29th, 2013 [June 29th, 2013]
- Stem Cell Transplant 2010 - Video - June 29th, 2013 [June 29th, 2013]
- Cml stem cell transplant Day (-6) - Video - July 1st, 2013 [July 1st, 2013]
- Stem Cell Transplant and Cellular Therapy Unit at CTCA in Philadelphia - Video - July 1st, 2013 [July 1st, 2013]
- CML Stem Cell Transplant Day (-5) - Video - July 4th, 2013 [July 4th, 2013]
- Ethan Zohn: What my stem cell transplant was like - Video - July 6th, 2013 [July 6th, 2013]
- Last of My Autologous Stem Cell Transplant - Video - July 7th, 2013 [July 7th, 2013]
- Cml stem cell transplant day (-1) - Video - July 7th, 2013 [July 7th, 2013]
- Stem Cell Transplant Survivors Meet by Dr. Chirag Shah Part 3 - Video - July 11th, 2013 [July 11th, 2013]
- Stem Cell Transplant Survivors Meet by Dr. Chirag Shah Part 2 - Video - July 11th, 2013 [July 11th, 2013]
- Stem Cell Transplant Survivors Meet by Dr. Chirag Shah Part 1 - Video - July 11th, 2013 [July 11th, 2013]
- Argentine boy heads home after stem cell transplant at Duke - July 12th, 2013 [July 12th, 2013]
- Helping Julia in her fight for a stem cell transplant - Video - July 28th, 2013 [July 28th, 2013]
- Stem cell transplant will give Katy teen a new lease on life - August 1st, 2013 [August 1st, 2013]
- Scientists identify biomarker to predict immune response risk after stem cell transplants - August 7th, 2013 [August 7th, 2013]
- Andrew Madoff Battling Stage-Four Cancer, Receives Donor Infusion After Stem Cell Transplant - August 10th, 2013 [August 10th, 2013]
- CML Stem cell transplant day (-2) - Video - August 10th, 2013 [August 10th, 2013]
- CML Stem cell transplant day +34 - Video - August 10th, 2013 [August 10th, 2013]
- India stem cell transplant - Video - August 11th, 2013 [August 11th, 2013]
- Local Stem Cell Transplant Program Keeping More Patients Closer to Home (KDFA-TV, Amarillo) - Video - August 12th, 2013 [August 12th, 2013]
- How to Say or Pronounce Stem Cell Transplant - Video - August 21st, 2013 [August 21st, 2013]
- Girl, 10, shows no sign of sickle cell after stem cell transplant in St. Louis - September 1st, 2013 [September 1st, 2013]
- Three months after risky stem cell transplant, young patient shows no signs of sickle cell - September 1st, 2013 [September 1st, 2013]
- Neil Mitchell chats to Mauro about his Stem Cell Transplant - Alfred Hospital - Video - September 2nd, 2013 [September 2nd, 2013]
- Lorelei Decker shares good news following stem cell transplant - September 25th, 2013 [September 25th, 2013]
- Adult Stem Cell Transplant Saves Tony Underhill from Scleroderma - Video - September 30th, 2013 [September 30th, 2013]
- Peter's Stem cell transplant Journey - Video - October 7th, 2013 [October 7th, 2013]
- Presque Isle infant needs stem cell transplant to beat life-threatening illness - October 13th, 2013 [October 13th, 2013]
- Stem cell transplant repairs damaged gut in mouse model of inflammatory bowel disease - October 18th, 2013 [October 18th, 2013]
- Study evaluates early stem cell transplants for non-Hodgkin's lymphoma - October 31st, 2013 [October 31st, 2013]
- Stem cell transplants : Cancer Research UK : CancerHelp UK - November 3rd, 2013 [November 3rd, 2013]
- Bone Marrow Transplant and Stem Cell Transplant Program, Siteman ... - November 3rd, 2013 [November 3rd, 2013]
- Stem cell transplants for non Hodgkin lymphoma : Cancer Research ... - November 3rd, 2013 [November 3rd, 2013]
- Katherine's stem cell transplant - Video - November 3rd, 2013 [November 3rd, 2013]
- Stem Cell Transplant - Dana-Farber Cancer Institute - November 11th, 2013 [November 11th, 2013]
- Peripheral Blood Stem Cell Transplant Donor, Procedure, Benefits ... - November 11th, 2013 [November 11th, 2013]
- A Journey Through A Stem Cell Transplant - Diane M. Sullivan - Video - November 11th, 2013 [November 11th, 2013]
- Bone Marrow - Dr B S Rajput Stem Cell Transplant Surgeon - Video - November 16th, 2013 [November 16th, 2013]
- Stem Cell Transplant Blog - November 18th, 2013 [November 18th, 2013]
- LHC Better Living: Stem Cell Transplant - Video - November 18th, 2013 [November 18th, 2013]
- India stem cell transplant by Dr B S Rajput stem cell transplant Surgeon - Video - November 21st, 2013 [November 21st, 2013]
- Stem Cell Transplants For Incurable and Untreatable Diseases ... - November 23rd, 2013 [November 23rd, 2013]
- Type of Treatment - Stem Cell Transplantation | MD Anderson ... - November 23rd, 2013 [November 23rd, 2013]
- Stem Cell Transplantations: Cancer Treatment | MD Anderson ... - November 24th, 2013 [November 24th, 2013]
- Datri 1st successful unrelated Blood Stem Cell Transplant - Video - November 24th, 2013 [November 24th, 2013]
- India stem cell transplant bone marrow by Dr. B. S. Rajput stem cell transplant surgeon - Video - November 26th, 2013 [November 26th, 2013]
- Stem Cell Transplants - Nemours: Kids Health - November 27th, 2013 [November 27th, 2013]
- Stem Cell Transplantation for Cancer Treatment | CTCA - November 29th, 2013 [November 29th, 2013]
- Bone Marrow/Stem Cell Transplant - Video - November 29th, 2013 [November 29th, 2013]
- Treatment Options - Stem Cell Transplantation - December 3rd, 2013 [December 3rd, 2013]
- Stem cell transplant: All - MayoClinic.com - December 4th, 2013 [December 4th, 2013]
- The Phases Of Stem Cell Transplant Treatment - Video - December 5th, 2013 [December 5th, 2013]
- Recurrent follicular lymphoma: Novel approaches vs stem cell transplant - Video - December 5th, 2013 [December 5th, 2013]
- Breakthrough in Treating Leukemia, Lymphoma Patients with Umbilical Cord Blood Stem Cells - December 12th, 2013 [December 12th, 2013]
- Advances in stem cell transplantation strategies show promise to improve availability, success - December 12th, 2013 [December 12th, 2013]
- Wilson undergoes transplant on Thursday - December 12th, 2013 [December 12th, 2013]
- Breakthrough in treating leukemia, lymphoma with umbilical cord blood stem cells - December 12th, 2013 [December 12th, 2013]
- HIV Returns in Two Men Thought Cured After Stem Cell Transplant - December 12th, 2013 [December 12th, 2013]
- Wilson resting following stem cell transplant - December 13th, 2013 [December 13th, 2013]
- Boyd: 'I am cancer-free' - December 15th, 2013 [December 15th, 2013]
- Bone Marrow Harvest for Stem Cell Transplant - Video - December 16th, 2013 [December 16th, 2013]
- Bone Marrow Stem Cell Transplant - Video - December 16th, 2013 [December 16th, 2013]
- Amyloidosis - Ongoing Research and Collaboration - Video - December 16th, 2013 [December 16th, 2013]
- Ruxolitinib before Stem Cell Transplant - Video - December 16th, 2013 [December 16th, 2013]
- The Multi Disciplinary Team Involved In A Stem Cell Transplant - Video - December 16th, 2013 [December 16th, 2013]
- Liver cells benefit from mesenchymal stem cell co-culture prior to transplantation - December 19th, 2013 [December 19th, 2013]
- Why Amyloidosis: Two Doctors Discuss Their Paths To The Disease - Video - December 19th, 2013 [December 19th, 2013]
- Debbie Stokes' stem cell transplant day video - Video - December 19th, 2013 [December 19th, 2013]